切换至 "中华医学电子期刊资源库"
高级检索
中华肾病研究电子杂志

中华肾病研究电子杂志 ›› 2020, Vol. 09 ›› Issue (04) : 159 -165. doi: 10.3877/cma.j.issn.2095-3216.2020.04.003

所属专题： 文献；

论著

心血管手术相关急性肾损伤患者行连续性肾脏替代治疗后的预后因素分析
刘珊1, 邬步云2, 刘康2, 俞香宝2, 朱亚梅2, 邵永丰3, 赵胜3, 邢昌赢2, 毛慧娟2,†()   
  1. 1. 210029　南京医科大学第一附属医院肾内科；222000　连云港市第二人民医院肾内科
    2. 210029　南京医科大学第一附属医院肾内科
    3. 210029　南京医科大学第一附属医院心脏大血管外科
  • 收稿日期:2020-05-07 出版日期:2020-08-28
  • 通信作者: 毛慧娟
  • 基金资助:
    国家自然基金面上项目(81970639); 江苏省教育厅六大人才高峰(WSN-056); 2017年江苏省卫生健康委员会科研项目(H2017023)

Analysis of prognostic factors in patients with cardiac and vascular surgery-related acute kidney injury after continuous renal replacement therapy

Shan Liu1, Buyun Wu2, Kang Liu2, Xiangbao Yu2, Yamei Zhu2, Yongfeng Shao3, Sheng Zhao3, Changying Xing2, Huijuan Mao2,†()   

  1. 1. Department of Nephrology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029; Department of Nephrology, Lianyungang Second People′s Hospital, Lianyungang 222000
    2. Department of Nephrology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029
    3. Department of Cardiovascular Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029; Jiangsu Province, China
  • Received:2020-05-07 Published:2020-08-28
  • Corresponding author: Huijuan Mao
  • About author:
    Corresponding author: Mao Huijuan, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

刘珊, 邬步云, 刘康, 俞香宝, 朱亚梅, 邵永丰, 赵胜, 邢昌赢, 毛慧娟. 心血管手术相关急性肾损伤患者行连续性肾脏替代治疗后的预后因素分析[J]. 中华肾病研究电子杂志, 2020, 09(04): 159-165.

Shan Liu, Buyun Wu, Kang Liu, Xiangbao Yu, Yamei Zhu, Yongfeng Shao, Sheng Zhao, Changying Xing, Huijuan Mao. Analysis of prognostic factors in patients with cardiac and vascular surgery-related acute kidney injury after continuous renal replacement therapy[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2020, 09(04): 159-165.

目的

探讨心血管手术相关急性肾损伤患者行连续性肾脏替代治疗后不同预后的相关因素。

方法

本研究纳入2015年1月至2018年12月在南京医科大学第一附属医院住院行心血管手术治疗且接受连续性肾脏替代治疗的患者，按90 d是否死亡和90 d内RRT治疗天数(≤14 d，15～90 d，>90 d)将患者分为4组，分析90 d死亡、90 d透析依赖、90 d延迟摆脱透析的相关影响因素。

结果

本研究共纳入210例患者，平均随访400 d。其中90 d死亡114例，90 d生存且14 d内摆脱透析37例，90 d生存15～90 d内摆脱透析46例，90 d生存且透析依赖13例。多因素Cox回归显示：90 d死亡的独立危险因素包括高龄(HR＝1.029，95%CI: 1.013～1.045，P<0.001)、术前血清肌酐低(HR＝0.993，95%CI: 0.987～0.998，P＝0.008)、CRRT前APACHE Ⅱ高评分(HR＝1.043, 95%CI: 1.004～1.084，P＝0.028)、CRRT前SOFA评分高(HR＝1.130, 95%CI: 1.052～1.213，P<0.001)、CRRT前脓毒症(HR＝2.327, 95%CI: 1.591～3.403，P<0.001)、CRRT前过低的舒张压(HR＝0.979，95%CI: 0.963～0.996，P＝0.013)。90 d存活患者透析依赖的独立危险因素包括术前较低的eGFR(HR＝0.962，95%CI: 0.940～0.984，P<0.001)。90 d存活患者中延迟摆脱透析的危险因素有血清白蛋白低(OR＝0.837，95%CI: 0.717～0.977，P＝0.024)、机械通气时间长(OR＝1.434，95%CI: 1.175～1.749，P<0.001)、CRRT前尿量少(OR＝0.739，95%CI: 0.623～0.876，P<0.001)。

结论

心血管手术相关急性肾损伤并行连续性肾脏替代治疗患者中，90 d死亡与高龄、CRRT前疾病的严重程度、脓毒症和过低的舒张压有关；90 d存活患者透析依赖与患者术前较差的肾功能有关；90 d存活患者延迟摆脱透析与血清白蛋白低、机械通气时间长、CRRT前尿量少有关。

关键词: 心血管手术相关急性肾损伤, 连续性肾脏替代治疗, 预后
Objective

To investigate the prognostic factors in patients with cardiac and vascular surgery-related acute kidney injury after continuous renal replacement therapy.

Methods

This study included patients admitted to the First Affiliated Hospital of Nanjing Medical University between January 2015 to December 2018, who underwent major cardiovascular surgery followed by continuous renal replacement therapy (CRRT). The patients were divided into 4 groups according to whether they survived within 90 days and the duration of RRT [≤14 days (rapid cessation), 15-90 days (delayed cessation), and >90 days (dialysis dependence)]. Risk factors for 90-day mortality, 90-day dialysis dependence, and 90-day delayed cessation of dialysis were analyzed.

Results

A total of 210 patients were included in this study, with an average follow-up duration of 400 days. Among them, 114 patients died within 90 days, 37 patients survived with rapid cessation of RRT, 46 patients survived with delayed cessation of RRT, and 13 patients survived with dialysis dependence. Multivariate Cox regression analysis showed that the independent risk factors of 90-day mortality included elder age (HR=1.029, 95%CI: 1.013-1.045, P<0.001), low level of preoperative serum creatinine (HR=0.993, 95%CI: 0.987-0.998, P=0.008), high score by APACHE Ⅱ before CRRT (HR=1.043, 95%CI: 1.004-1.084, P=0.028), high score by SOFA before CRRT (HR=1.130, 95%CI: 1.052-1.213, P<0.001), sepsis before CRRT (HR=2.327, 95%CI: 1.591-3.403, P<0.001), and low level of diastolic blood pressure before CRRT (HR=0.979, 95%CI: 0.963-0.996, P=0.013). The independent risk factors for patients survived with dialysis dependence consisted of low preoperative eGFR (HR=0.962, 95%CI: 0.940-0.984, P<0.001). The risk factors for patients survived with delayed cessation of dialysis were low level of serum albumin (OR=0.837, 95%CI: 0.717-0.977, P=0.024), long duration of mechanical ventilation (OR=1.434, 95%CI: 1.175-1.749, P<0.001), and low level of urine volume before CRRT (OR=0.739, 95%CI: 0.623-0.876, P<0.001).

Conclusion

In patients with cardiovascular surgery-associated acute kidney injury requiring CRRT, 90-day mortality was associated with elder age, severity of disease, sepsis, and low level of diastolic blood pressure before CRRT. Patients survived at 90-day having dialysis dependence were associated with poor preoperative renal function. Patients survived at 90-day having delayed cessation of dialysis were associated with low level of serum albumin, long duration of mechanical ventilation, and low level of urine volume before CRRT.

Key words: Cardiovascular surgery-related acute kidney injury, Continuous renal replacement therapy, Prognosis
表1 患者的基线资料
变量 90 d死亡(n＝114) 90 d生存 P值
快速摆脱透析(n＝37) 延迟摆脱透析(n＝46) 透析依赖(n＝13)
一般资料 ? ? ? ? ?
? 男性[n(%)] 65(57.0) 23(62.2) 35(76.1) 9(69.2) 0.150
? 年龄(岁) 66(55，73) 56(52，70) 55(42，66) 67(60，70) <0.001
? BMI(kg/m2) 22.8(20.8，26.2) 24.6(22.8，26.8) 24.2(21.0，27.8) 25.4(21.7，26.8) 0.148
? 高血压[n(%)] 67(58.8) 23(62.2) 23(50.0) 10(76.9) 0.337
? 糖尿病[n(%)] 18(15.8) 9(24.3) 6(13.0) 5(38.5) 0.123
? Charlson合并症评分 1(0，2) 1(0，2) 1(0，1) 3(1，5) 0.001
? NT-ProBNP(10 ng/L) 164(72，338) 227(95，348) 90(47，153) 547(182，900) 0.002
? 血白蛋白(g/L) 35.5(33.1，33.8) 37.0(35.2，39.0) 35.4(31.8，38.7) 35.2(33.6，37.0) 0.207
? 左心射血分数(%) 62(56，65) 60(50，63) 62(52，65) 59(53，63) 0.289
? 术前血清肌酐(μmol/L) 79(67，98) 82(71，114) 78(66，106) 161(98，222) 0.001
? eGFR [ml/(min·1.73 m2)] 79(61，94) 79(55，98) 90(59，110) 38(21，65) <0.001
手术类型[n(%)] ? ? ? ? 0.016
? 瓣膜 46(40.4) 18(48.6) 17(37.0) 5(38.5) ?
? CABG 19(16.7) 6(16.2) 3(6.5) 5(38.5) ?
? 瓣膜＋CABG 15(13.2) 3(8.1) 2(4.3) 3(23.1) ?
? 主动脉 23(20.2) 9(24.3) 15(32.6) 0(0.00) ?
? 其他 11(9.6) 1(2.7) 9(19.6) 0(0.00) ?
手术信息 ? ? ? ? ?
? 体外循环[n(%)] 94(82.5) 31(83.8) 43(93.5) 8(61.5) 0.045
? 体外循环(min) 158(95，210) 176(123，222) 187(122，236) 108(0，156) 0.026
? 手术时间(min) 376(282，515) 350(280，495) 438(315，540) 280(241，327) 0.009
术后指标 ? ? ? ? ?
? 机械通气(d) 8(4，12) 2(0.5，5.0) 5(2，9) 4(1，5) <0.001
? 降钙素原(ng/ml) 11.2(3.2，32.7) 3.6(1.4，10.6) 10.2(4.3，18.1) 9.8(5.2，13.2) 0.025
CRRT前状态 ? ? ? ? ?
? APACHE Ⅱ评分 20(12，24) 14(10，16) 14(12，17) 14(12，16) 0.001
? SOFA评分 14(11，17) 10(8，12) 12(10，14) 10(9，12) <0.001
? 脓毒症[n(%)] 50(43.8) 4(10.8) 4(8.7) 3(23.1) <0.001
? 明显高钾血症[n(%)] 6(5.2) 1(2.7) 1(2.2) 3(23.1) 0.022
? 血管活性药物评分 24.0(10，41) 4(0，17.5) 12(6.5，37.3) 15(2.5，19) <0.001
? 收缩压(mmHg) 108(98，119) 117(106，125) 114(101，130) 113(101，128) 0.060
? 舒张压(mmHg) 54(48，60) 64(50，72) 60(53，64) 61(54，63) 0.002
? 中心静脉压(mmHg) 14(10，18) 14(12，16) 12(10，14) 11(9，14) 0.025
? 尿素氮(mmol/L) 17(12，28) 17(14，26) 16(13，21) 18(16，24) 0.490
? 血清肌酐(μmol/L) 182(150，259) 240(183，339) 255(197，370) 332(260，361) <0.001
? 入量(100 ml) 32.8(29.0，39.3) 30.0(23.9，35.2) 34.7(26.9，41.8) 30.1(21.3，35.8) 0.016
? 尿量(100 ml) 4.5(1.8，10.6) 9.4(6.1，17.1) 4.4(1.5，7.5) 5.7(3.2.12.7) <0.001
表2 使用Cox回归分析90 d死亡的相关因素(n＝210)
变量 单因素 多因素
HR(95%CI) P值 HR(95%CI) P值
性别(男性) 0.661(0.456～0.959) 0.029 ? ?
年龄(岁) 1.034(1.017～1.051) <0.001 1.029(1.013～1.045) <0.001
体重(kg) 0.979(0.964～0.993) 0.004 ? ?
术前血清肌酐(μmol/L) 0.994(0.990～0.999) 0.020 0.993(0.987～0.998) 0.008
机械通气时间(d) 1.022(1.006～1.038) 0.006 ? ?
CRRT前脓毒症(1/0) 3.086(2.124～4.484) <0.001 2.327(1.591～3.403) <0.001
CRRT前APACHE Ⅱ评分 1.079(1.048～1.111) <0.001 1.043(1.004～1.084) 0.028
CRRT前SOFA评分 1.198(1.130～1.270) <0.001 1.130(1.052～1.213) <0.001
CRRT前收缩压(mmHg) 0.985(0.975～ 0.995) 0.004 ? ?
CRRT前舒张压(mmHg) 0.968(0.952～0.984) <0.001 0.979(0.963～0.996) 0.013
CRRT前血管活性药物评分 1.012(1.007～1.018) <0.001 ? ?
CRRT前24 h入量(100 ml) 1018(1.005～1.031) 0.008 ? ?
表3 使用Cox回归分析90 d存活患者透析依赖的相关因素(n＝96)
变量 单因素 多因素
HR(95%CI) P值 HR(95%CI) P值
年龄(岁) 1.061(1.005～1.119) 0.031 ? ?
术前血清肌酐(μmol/L) 0.010(1.005～1.015) <0.001 ? ?
术前eGFR [ml/(min·1.73 m2)] 0.962(0.940～0.984) <0.001 0.962(0.940～0.984) <0.001
Charlson合并症评分 1.560(1.237～1.967) <0.001 ? ?
手术时间(min) 0.993(0.988～0.998) 0.009 ? ?
明显高钾血症(1/0) 5.460(1.503～19.839) 0.010 ? ?
[1]
Bellomo R, Auriemma S, Fabbri A, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI) [J]. Int J Artif Organs, 2008, 31(2): 166-178.
[2]
Nadim MK, Forni LG, Bihorac A, et al. Cardiac and vascular surgery-associated acute kidney injury: the 20th international consensus conference of the ADQI (Acute Disease Quality Initiative) Group [J]. J Am Heart Assoc, 2018, 7(11): e008834.
[3]
Xie X, Wan X, Ji X, et al. Reassessment of acute kidney injury after cardiac surgery: a retrospective study [J]. Intern Med, 2017, 56(3): 275-282.
[4]
Pickering JW, James MT, Palmer SC. Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies [J]. Am J Kidney Dis, 2015, 65(2): 283-293.
[5]
Thakar CV, Worley S, Arrigain S, et al. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function [J]. Kidney Int, 2005, 67(3): 1112-1119.
[6]
Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment [J]. Nat Rev Nephrol, 2017, 13(11): 697-711.
[7]
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury [J]. Nephron Clin Pract, 2012, 120(4): c179-c184.
[8]
Vidal S, Richebé P, Barandon L, et al. Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery [J]. Eur J Cardiothorac Surg, 2009, 36(3): 572-579.
[9]
Pistolesi V, Di Napoli A, Fiaccadori E, et al. Severe acute kidney injury following cardiac surgery: short-term outcomes in patients undergoing continuous renal replacement therapy (CRRT) [J]. J Nephrol, 2016, 29(2): 229-239.
[10]
Thongprayoon C, Cheungpasitporn W, Shah IK, et al. Long-term outcomes and prognostic factors for patients requiring renal replacement therapy after cardiac surgery [J]. Mayo Clin Proc, 2015, 90(7): 857-864.
[11]
Seymour CW, Liu VX, Iwashyna TJ，et al. Assessment of clinical criteria for sepsis：for the Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J]. JAMA, 2016, 315(8): 762-774.
[12]
Perez-Valdivieso JR, Monedero P, Vives M, et al. Cardiac-surgery associated acute kidney injury requiring renal replacement therapy. A Spanish retrospective case-cohort study [J]. BMC Nephrol, 2009, 10: 27.
[13]
Landoni G, Zangrillo A, Franco A, et al. Long-term outcome of patients who require renal replacement therapy after cardiac surgery [J]. Eur J Anaesthesiol, 2006, 23(1): 17-22.
[14]
Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery [J]. Am J Med, 1998, 104(4): 343-348.
[15]
Van Den Noortgate N, Mouton V, Lamot C, et al. Outcome in a post-cardiac surgery population with acute renal failure requiring dialysis: does age make a difference? [J]. Nephrol Dial Transplant, 2003, 18(4): 732-736.
[16]
Baudouin SV, Wiggins J, Keogh BF, et al. Continuous veno-venous haemofiltration following cardio-pulmonary bypass. Indications and outcome in 35 patients [J]. Intensive Care Med, 1993, 19(5): 290-293.
[17]
Haanschoten MC, van Straten AH, Bouwman A, et al. Impact of postoperative renal replacement therapy on long-term outcome after cardiac surgery increases with age [J]. J Card Surg, 2014, 29(4): 464-469.
[18]
Rigamonti F, Graf G, Merlani P, et al. The short-term prognosis of cardiogenic shock can be determined using hemodynamic variables: a retrospective cohort study [J]. Crit Care Med, 2013, 41(11): 2484-2491.
[19]
Howitt SH, Herring M, Malagon I, et al. Incidence and outcomes of sepsis after cardiac surgery as defined by the Sepsis-3 guidelines [J]. Br J Anaesth, 2018, 120(3): 509-516.
[20]
Drosos G, Ampatzidou F, Sarafidis P, et al. Serum creatinine and chronic kidney disease-epidemiology estimated glomerular filtration rate: independent predictors of renal replacement therapy following cardiac surgery [J]. Am J Nephrol, 2018, 48(2): 108-117.
[21]
Joannidis M, Forni LG, Klein SJ, et al. Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup [J]. Intensive Care Med, 2020, 46(4): 654-672.
[22]
Kao KC, Hu HC, Fu JY, et al. Renal replacement therapy in prolonged mechanical ventilation patients with renal failure in Taiwan [J]. J Crit Care, 2011, 26(6): 600-607.
[23]
Badenes R, Lozano A, Belda FJ, et al. Postoperative pulmonary dysfunction and mechanical ventilation in cardiac surgery [J]. Crit Care Res Pract, 2015, 2015: 420513.
[24]
Hessels L, Coulson TG, Seevanayagam S, et al. Development and validation of a score to identify cardiac surgery patients at high risk of prolonged mechanical ventilation [J]. J Cardiothorac Vasc Anesth, 2019, 33(10): 2709-2716.
[25]
Mathis MR, Duggal NM, Likosky DS, et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery [J]. Anesthesiology, 2019, 131(5): 1046-1062.
[26]
Oh HJ, Shin DH, Lee MJ, et al. Urine output is associated with prognosis in patients with acute kidney injury requiring continuous renal replacement therapy [J]. Crit Care, 2013, 28(4): 379-388.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志（电子版）, 2023, 20(06): 581-587.
[2] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[3] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[4] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[5] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[6] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[7] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[8] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[9] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[10] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[11] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[12] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号